Company intelligence / Profile preview

Swing Therapeutics

San Francisco, California, United Statesswingtherapeutics.com ↗
Ownership
Private
Employees
~23
Development stage
Commercial
01

Overview

Stanza demonstrated statistically significant and clinically meaningful improvements in wellbeing, fibromyalgia severity, and major symptoms associated with fibromyalgia—including pain intensity, fatigue, sleep disturbance, depression—without treatment-related safety events. The pivotal PROSPER-FM Phase 3 randomized controlled trial was the largest RCT undertaken on fibromyalgia treatment devices. Stanza received FDA De Novo marketing authorization in May 2023.

Therapeutic areas
RheumatologyImmunologyNeurology
Modalities
Non-pharmacological therapy (digital behavioral therapy)Device (prescription digital therapeutic)
Industry
Digital Health Medical Devices
02

Drug pipeline

1 asset

Stanza

Commercial
Indications
Fibromyalgia
03

Partnerships

University of Manitoba (licensed foundational clinical program)No major pharmaceutical partnerships disclosed.

Beyond the preview

Go deeper on Swing Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Swing Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call